Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kunfukang
- Development stage
- Unknown
- Lead developer
- Shaanxi Kanghui Pharmaceutical
- Administration
- Oral
01
Overview
Kunfukang is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shaanxi Kanghui Pharmaceutical. It is primarily indicated for the treatment of gynecological inflammatory conditions, specifically pelvic inflammatory disease (PID) and its sequelae, including chronic pelvic pain and leukorrhea (vaginal discharge). Available in both capsule and tablet forms, the medication is formulated according to TCM principles to clear heat, resolve dampness, detoxify, and promote blood circulation to remove stasis. Clinical research has investigated its therapeutic effects on immune molecular mechanisms and its impact on vaginal microecology in patients suffering from chronic pelvic inflammation.
- Brand names
- Kunfukang坤复康
- Other names
- Kunfukang CapsuleKunfukang TabletKunfukang jiaonangKunfukang pian坤复康胶囊坤复康片
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL8 (C-X-C Motif Chemokine Ligand 8)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Kunfukang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kunfukang.